These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24827764)

  • 21. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
    Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-cell-activating factor receptor expression on naive and memory B cells: relationship with relapse in patients with rheumatoid arthritis following B-cell depletion therapy.
    de la Torre I; Moura RA; Leandro MJ; Edwards J; Cambridge G
    Ann Rheum Dis; 2010 Dec; 69(12):2181-8. PubMed ID: 20581016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic analysis of B-cell subsets in de novo living related kidney transplantation with induction therapy of basiliximab.
    Longshan L; Dongwei L; Qian F; Jun L; Suxiong D; Yitao Z; Yunyi X; Huiting H; Lizhong C; Jiguang F; Changxi W
    Transplant Proc; 2014; 46(2):363-7. PubMed ID: 24655964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
    Thiyagarajan UM; Bagul A; Frost J; Horsburgh T; Nicholson ML
    Transplant Proc; 2012 Jun; 44(5):1231-5. PubMed ID: 22663991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-human leukocyte antigen immunization after early allograft nephrectomy.
    Del Bello A; Congy N; Sallusto F; Cardeau-Desangles I; Fort M; Esposito L; Guitard J; Cointault O; Lavayssière L; Nogier MB; Game X; Blancher A; Rostaing L; Kamar N
    Transplantation; 2012 May; 93(9):936-41. PubMed ID: 22361471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-specific B cells: II. Application to transplantation.
    Zachary AA; Kopchaliiska D; Montgomery RA; Melancon JK; Leffell MS
    Transplantation; 2007 Apr; 83(7):989-94. PubMed ID: 17460572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
    Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and risk factors of anti-HLA immunization after pregnancy.
    Masson E; Vidal C; Deschamps M; Bongain S; Thevenin C; Dupont I; Rietmulher D; Pouthier F; Mongaillard G; Chabod J; Ferrand C; Tiberghien P; Rebibou JM
    Hum Immunol; 2013 Aug; 74(8):946-51. PubMed ID: 23628391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection.
    Banham G; Prezzi D; Harford S; Taylor CJ; Hamer R; Higgins R; Bradley JA; Clatworthy MR
    Transplantation; 2013 Aug; 96(4):413-20. PubMed ID: 23842189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo produced anti-human leukocyte antigen antibodies relation to alloimmunity in patients with chronic renal failure.
    Pirim I; Soyoz M; Ayna TK; Kocyigit AO; Gurbuz BC; Tugmen C; Kurtulmus Y; Ozyilmaz B
    Genet Test Mol Biomarkers; 2015 Jun; 19(6):335-8. PubMed ID: 25826018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.
    Pers JO; Devauchelle V; Daridon C; Bendaoud B; Le Berre R; Bordron A; Hutin P; Renaudineau Y; Dueymes M; Loisel S; Berthou C; Saraux A; Youinou P
    Arthritis Rheum; 2007 May; 56(5):1464-77. PubMed ID: 17469105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular IFNgamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization.
    Toyoda M; Pao A; Vo A; Lukovsky M; Radha R; Sado T; Ge S; Reinsmoen N; Chai NN; Baden L; Petrosyan A; Skinner E; Mirocha J; Jordan SC
    Transpl Immunol; 2010 Feb; 22(3-4):121-7. PubMed ID: 19944759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus.
    Carter LM; Isenberg DA; Ehrenstein MR
    Arthritis Rheum; 2013 Oct; 65(10):2672-9. PubMed ID: 23839909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.
    Bosch A; Llorente S; Diaz JA; Salgado G; López M; Boix F; López-Hernández R; González-Soriano MJ; Campillo JA; Moya-Quiles MR; Perez-Lopez N; Minguela A; Jimeno L; Alvarez-López MR; Muro M
    Hum Immunol; 2012 May; 73(5):522-5. PubMed ID: 22425738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.
    Cardarelli F; Pascual M; Tolkoff-Rubin N; Delmonico FL; Wong W; Schoenfeld DA; Zhang H; Cosimi AB; Saidman SL
    Transpl Int; 2005 May; 18(5):532-40. PubMed ID: 15819801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated serum levels of B-cell activating factor in pediatric renal transplant patients.
    Lehnhardt A; Dunst F; van Husen M; Loos S; Oh J; Eiermann T; Koch M; Kemper MJ
    Pediatr Nephrol; 2012 Aug; 27(8):1389-95. PubMed ID: 22453734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.